Cargando…
Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention
Hepatitis B virus (HBV) infection remains a global health problem with over 350 million chronically infected, causing an increased risk of cirrhosis and hepatocellular carcinoma. Current antiviral chemotherapy for HBV infection include five nucleos(t)ide analog reverse transcriptase inhibitors (NRTI...
Autores principales: | Jones, Scott A, Hu, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820986/ https://www.ncbi.nlm.nih.gov/pubmed/26038488 http://dx.doi.org/10.1038/emi.2013.56 |
Ejemplares similares
-
Differential Binding of Tenofovir and Adefovir to Reverse Transcriptase of Hepatitis B Virus
por: van Hemert, Formijn J., et al.
Publicado: (2014) -
Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression
por: Choi, Yu-Min, et al.
Publicado: (2018) -
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
por: Yang, Xunjun, et al.
Publicado: (2016) -
Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
por: Sze, Karen Man‐Fong, et al.
Publicado: (2020) -
Pre-Existing Mutations in Reverse Transcriptase of Hepatitis B Virus in Treatment-Naive Chinese Patients with Chronic Hepatitis B
por: Xu, Jie, et al.
Publicado: (2015)